epibatidine has been researched along with am 251 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Higashi, Y; Nakamura, K; Saito, M; Shimizu, S; Shimizu, T; Tanaka, K; Taniuchi, K; Ueba, T; Yawata, T; Yuri, K | 1 |
1 other study(ies) available for epibatidine and am 251
Article | Year |
---|---|
Possible inhibitory role of endogenous 2-arachidonoylglycerol as an endocannabinoid in (±)-epibatidine-induced activation of central adrenomedullary outflow in the rat.
Topics: Adrenal Medulla; Animals; Arachidonic Acids; Bridged Bicyclo Compounds, Heterocyclic; Catecholamines; Dose-Response Relationship, Drug; Endocannabinoids; Glycerides; Immunohistochemistry; Male; Neurons; Neurotransmitter Agents; Nicotinic Agonists; Paraventricular Hypothalamic Nucleus; Piperidines; Pyrazoles; Pyridines; Rats, Wistar; Receptor, Cannabinoid, CB1 | 2015 |